SCHEMBL24773385

SCHEMBL24773385

C=C(F)C(=O)Nc1ccc(-c2ncnc(N)c2-c2ccc(Oc3nccc(C)n3)c(F)c2)c(OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 2/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ CYP2D6 P10635 1/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ FGFR2 P21802 1/20 0.57
▸ FGFR4 P22455 1/20 0.57
▸ FGFR3 P22607 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ ALOX5AP P20292 2/20 0.39
▸ FEN1 P39748 2/20 0.39
▸ JAK3 P52333 3/20 0.36
▸ KDR P35968 3/20 0.35
▸ MET P08581 3/20 0.35
▸ KIT P10721 3/20 0.35
▸ FLT3 P36888 2/20 0.35
▸ AXL P30530 2/20 0.35
▸ AURKA O14965 1/20 0.35
▸ PDPK1 O15530 1/20 0.35
▸ DYRK3 O43781 1/20 0.35
▸ ROCK2 O75116 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24772971 0.90 FGFR1 (0.64) FGFR1CYP3A4CYP2D6CYP2C9FGFR2
SCHEMBL24772963 0.90 FGFR4 (0.52) FGFR1CYP3A4CYP2D6CYP2C9FGFR2
SCHEMBL24772959 0.86 CYP3A4 (0.66) FGFR1CYP3A4CYP2D6CYP2C9FGFR2
SCHEMBL24773387 0.84 CYP3A4 (0.45) FGFR1CYP3A4CYP2D6CYP2C9FGFR2
SCHEMBL24772967 0.84 CYP3A4 (0.63) FGFR1CYP3A4CYP2D6CYP2C9FGFR2
SCHEMBL24773300 0.84 CYP3A4 (0.73) FGFR1CYP3A4CYP2D6CYP2C9FGFR2
SCHEMBL30680174 0.84 CYP3A4 (0.73) FGFR1CYP3A4CYP2D6CYP2C9FGFR2
SCHEMBL24772972 0.82 FGFR4 (0.53) FGFR1CYP3A4CYP2D6CYP2C9FGFR2
SCHEMBL31213902 0.82 FGFR1 (0.59) FGFR1CYP3A4CYP2D6CYP2C9FGFR2
SCHEMBL24773386 0.81 FGFR1 (0.61) FGFR1CYP3A4CYP2D6CYP2C9FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022206939-A1 HETEROCYCLIC COMPOUND SERVING AS FGFR INHIBITOR AND APPLICATION THEREOF 海南耀臻生物医药科技有限公司 2022-10-06 — — WO disclosed
Send feedback